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ATVB publishes research work that advances scientific fields in a rigorous and reproducible manner. We have imple-
mented multiple approaches to follow the National Institutes 
of Health guidelines for rigor and reproducibility. In 2013, 
ATVB developed a checklist in the peer review process to facil-
itate comments on multiple technical requirements, including 
the sex of animals used in preclinical studies. We have also 
emphasized the National Institutes of Health guidelines that 
encourage researchers to study both sexes in preclinical ani-
mal models. These include publishing a review1 entitled “Sex 
Differences in the Development of Cardiovascular Diseases” 
and an ATVB Council statement2 to encourage authors to con-
sider sex differences in designing and reporting experimental 
arterial pathology studies that detail the mode by which ATVB 
complies with the National Institutes of Health guidelines.3 
The journal appointed a technical review editor, Dr Hong Lu, 
who assumed the role in September 2017 to assess the many 
elements required for adherence to the National Institutes of 
Health guidelines. These include issues such as the rigor of 
statistical analyses and animal background strain, age, and 
sex. The designation of sex of origin in studies of primary 
cells derived from cell culture is not as common as it is in ani-
mal studies. This is probably because of the unproven assump-
tion that the lack of the hormonal environment in cell culture 
eliminates the need for designation of sex. However, because 
the differences of X and Y sex chromosomes and possibly 
sex-related differences in genomic imprinting are preserved 
in cultured cells, these cells could theoretically retain the abil-
ity to respond in a sex-dependent manner.4 Therefore, we also 
encourage and will monitor the reporting of sex in primary 
cell isolation and culture.
In a recent letter to the ATVB editors, Ramirez and Hibbert5 
performed a comprehensive literature search and detailed sta-
tistical analysis on articles focusing on preclinical research of 
atherosclerosis and aneurysms from 2006 through 2016. They 
concluded that publication of guidelines and statements alone is 
not sufficient to assure the reporting of sex and sex differences 
in preclinical studies. To more objectively assess whether and 
how sex information in preclinical research has been reported, 
the ATVB editors reviewed 332 basic science research articles 
published in ATVB between 2016 and 2017.6–337 After excluding 
those that studied only human samples, human cells, cell lines, 
or computational models, 159 articles published in 2016 and 
136 articles published in 2017 were analyzed (Tables 1 through 
5), which reported studies in animal models or primary cells 
isolated from animals.6–300 There were 7 species reported in 
these articles (Table 1), including zebrafish, mouse, rat, rabbit, 
dog, pig, and nonhuman primates. Among these 295 articles 
analyzed, 79% and 92% of those from 2016 to 2017, respec-
tively, provided sex information for in vivo models. However, 
only 11% of the articles in 2016 and 21% in 2017 reported 
results from both males and females. One hundred and thirty-
three of the 295 articles reported primary cells isolated from 
mouse, rat, cow, or pig. Twenty-eight percent of the articles in 
2016 and 27% in 2017 provided sex information, whereas only 
3 articles studied cells from both male and female animals.
In this article, we provide the results of analysis of reported 
data on sex from animal models (Tables 2 through 5) and pri-
mary animal cell cultures among basic science articles pub-
lished in ATVB between 2016 and 2017.6–300 We also discuss 
what we have already implemented and what we will do in the 
future to encourage authors to report findings from both sexes 
in preclinical studies. We will continue to monitor and docu-
ment the analytic results of reporting sex and sex differences 
in ATVB on an annual basis.
Zebrafish
Zebrafish have become an increasingly valuable model to study 
cardiovascular development and functions. Zebrafish breed 
prodigiously and generate large numbers of offspring rapidly. 
Their larvae are transparent, which make many anatomic fea-
tures easily visible during development. Zebrafish have simi-
lar genetic structure and organ distributions to humans and 
share ≈70% of their genome with humans.338 The popularity 
and value of zebrafish research have also been reflected by 
the number of research articles published recently in ATVB. In 
2016 and 2017, 8 articles reported zebrafish models,6–13 involv-
ing studies of lipoprotein signaling, endothelial development 
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and functions, angiogenesis, and lymphangiogenesis. These 
articles studied zebrafish at stages during embryonic or larval 
development when the sex cannot be identified.
Sex determination is more complicated compared with 
mammalian organisms because zebrafish do not have sex 
chromosomes.339,340 However, there are multiple features that 
can help identify male and female zebrafish at the adult stage. 
Because sexual dimorphism has been noted in zebrafish (in a 
few examples341–344), the ATVB editors encourage authors to 
study both sexes and provide the sex identification informa-
tion if adult zebrafish are studied. If the sex cannot be identi-
fied before the adult stage, we encourage the authors to briefly 
state this potential limitation in the Methods section.
Rodent Models
Rodents are the most common species used to study cardio-
vascular functions and diseases. The most popular species are 
mice and rats. Among the 295 articles analyzed, 251 (85%) 
articles reported mouse models,14–264 114 (39%) reported 
results on primary cells isolated from mice, 21 (7%) reported 
rat models,265–285 and 14 (5%) reported results on primary 
cells isolated from rats. For in vivo studies, 84% of the arti-
cles reported sex in mouse models, and 95% reported sex in 
rat models after exclusion of those that only used embryos 
or neonates. The most commonly studied sex is male in both 
mice and rats (Tables 3 and 4). In adult mice and rats, the 
estrous cycle is ≈4 to 5 days, which leads to striking changes 
in sex hormones during this brief interval.345,346 In addition, 
some cardiovascular diseases have milder phenotypes in 
females than in males.1,3 For these reasons, many researchers 
elect to focus their studies on male rodents, especially in mice.
For articles that studied rodent primary cell cultures, 
after excluding those that used cells from neonates, sex was 
reported in ≈25% and 40% of the studies in mice and rats, 
respectively. Many studies included both in vivo studies and 
primary cell cultures from the rodent model. Most articles 
specified the sex of animals in the Methods section but did not 
provide sex information for primary cell isolation and culture. 
Although it is very possible that same sex was used for both in 
vivo and in vitro studies, our analysis only counted the articles 
that clearly stated sex information in the primary cell isolation 
and culture sections.
ATVB publishes articles that cover a spectrum of research 
areas on lipoprotein metabolism, atherosclerosis, thrombosis, 
and vascular biology, and related diseases. Sex differences 
are an important feature of these cardiovascular physio-
logical and pathological states. One example is angiotensin 
II-induced abdominal aortic aneurysm that was discussed 
in the recent ATVB Council statement.2 The incidence of 
angiotensin II-induced abdominal aortic aneurysm is ≈80% 
to 100% in male hypercholesterolemic mice but only ≈10% 
in female mice with the same genetic background. Although 
the first publication in apolipoprotein E-deficient mice used 
females,347 the vast majority of subsequent studies evaluated 
only male mice,348 except for a few articles that have studied 
sex differences of the disease in this mouse model. Therefore, 
if a strong sexual dimorphism has already been identified and 
recognized by the research community, the ATVB editors rec-
ommend monitoring this specific issue and suggest that the 
authors provide a succinct justification in their manuscripts as 
to why a specific sex was studied. Otherwise, we recommend 
that the authors study both male and female rodent models.
Large Animal Models
Large animals are more expensive to maintain and study than 
rodent models, and thus data are frequently derived from rela-
tively small sample sizes. However, these larger models may 
have more relevance to human physiological and pathophysi-
ological conditions.349 For example, atherosclerotic plaque 
rupture—a potentially fatal clinical condition—does not occur 
in the most commonly used mouse models of atherosclero-
sis.349 In addition, a common and disease-relevant location of 




Zebrafish 5 3 6–13
Mouse 134 117 14–264
Rat 10 11 265–285
Rabbit 2 4 286–291
Dog 1 0 263
Pig 2 4 11,292,293,295–297
Primate 3 0 298–300
Table 2. Reporting Sex of Animals in Preclinical Studies
Species












Male, % 60 53
Female, % 7 15
Both male and female, % 11 23




Male, % 90 91
Female, % 10 0
Both male and female, % 0 0
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human atherosclerosis is the coronary arteries, but atheroscle-
rosis does not occur in coronary artery branches of mice.350 
Large animals, especially pigs and nonhuman primates, not 
only mimic multiple features of human diseases but also are 
valuable to test drug toxicology and potency. Therefore, the 
editors acknowledge the importance of and encourage cardio-
vascular research studies using large animals.
In articles published between 2016 and 2017 in ATVB, 6 
studied rabbit models,286–291 1 studied a dog model,263 6 stud-
ied pig models,11,292,293,295–297 and 3 studied nonhuman pri-
mate studies.298–300 Among these 16 articles, 81% reported 
sex, 2 articles studied both sexes in rabbits, and 1 article 
reported both sexes in dogs (Table 5). There are multiple 
issues that limit large animal studies, such as sample size, 
the cost, and study duration. Although the journal does not 
require that both sexes should be evaluated in large animal 
studies, it is suggested that authors state clearly the sex of 
animals, provide a necessary justification as to why a spe-
cific sex was studied, and discuss the potential limitation if 
only 1 sex was studied.
Perspectives
ATVB implemented the technical review mechanism in 
September 2017, which did not impact reporting sex in the 
articles that were reviewed and analyzed between 2016 and 
2017 (Tables 1 through 5). However, we note that more 
articles have reported both male and female mouse data (26 
articles) in 2017, compared with publications (15 articles) 
in 2016 (Table 3). For those that only studied a single sex, 
reporting of female mice has also increased (17 articles in 
2017 versus 9 articles in 2016; Table 3). The editors expect 
that this recently instituted technical review process will lead 
to a further increase in the reporting of sex and sex differences 
in ATVB.
The ATVB editors will evaluate each original research 
article with the following specific requests for reporting sex:
1. Sex of in vivo animal models and ex vivo primary cell 
culture studies must be clearly stated in the Methods sec-
tion, Results section, tables, and figure legends.
2. If the authors studied only 1 sex, the authors will be 
asked to provide a justification for the selection of this 
specific sex.
We also recommend that the authors state the potential limi-
tations of studying a single sex in either the Methods or 
Discussion section. The ATVB editors appreciate the respon-
siveness of authors to study sex differences in preclinical mod-
els more frequently. We hope that this continued effort from 
both the editors and authors will help the research community 
to enhance understanding and exploring sex differences of 
cardiovascular functions and diseases.
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